OC-0591: Phase III randomized trial comparing two modalities of RS for brain metastases: Gammaknife vs Linac. (April 2018) - Palumbo, V.; Navarria, P.; Tomatis, S.; Clerici, E.; Carta, G.A.; Picozzi, P.; Mancosu, P.; Scorsetti, M.